牛牛AI助理已提取核心訊息
Moderna, Inc.'s Chief Legal Officer, Shannon Thyme Klinger, completed a series of transactions involving the company's common stock. On March 1, 2024, Klinger acquired 233 shares through the exercise of derivative securities. Subsequently, on March 4, 2024, Klinger sold 117 shares on the open market at a price of $94.3383 per share. Following these transactions, Klinger's direct holdings in Moderna common stock amounted to 8,673 shares. The total market value of the disposed shares was approximately $11,037.58.
Moderna, Inc.'s Chief Legal Officer, Shannon Thyme Klinger, completed a series of transactions involving the company's common stock. On March 1, 2024, Klinger acquired 233 shares through the exercise of derivative securities. Subsequently, on March 4, 2024, Klinger sold 117 shares on the open market at a price of $94.3383 per share. Following these transactions, Klinger's direct holdings in Moderna common stock amounted to 8,673 shares. The total market value of the disposed shares was approximately $11,037.58.
Moderna, Inc. '的首席法務官香農·泰裏姆·克林格完成了一系列涉及公司普通股的交易。2024年3月1日，克林格通過行使衍生證券收購了233股股票。隨後，克林格於2024年3月4日在公開市場上以每股94.3383美元的價格出售了117股股票。這些交易之後，克林格直接持有的Moderna普通股爲8,673股。已處置股票的總市值約爲11,037.58美元。
Moderna, Inc. '的首席法務官香農·泰裏姆·克林格完成了一系列涉及公司普通股的交易。2024年3月1日，克林格通過行使衍生證券收購了233股股票。隨後，克林格於2024年3月4日在公開市場上以每股94.3383美元的價格出售了117股股票。這些交易之後，克林格直接持有的Moderna普通股爲8,673股。已處置股票的總市值約爲11,037.58美元。
有用
沒用